Cargando…

Genome-wide association study suggests impact of chromosome 10 rs139401390 on kidney function in patients with coronary artery disease

Chronic kidney disease (CKD) is an independent risk factor for onset and progression of coronary artery disease (CAD). Discovery of predisposing loci for kidney function in CAD patients was performed using a genome-wide association approach. Inclusion criteria were CAD with ≥50% stenosis (≥1 coronar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitz, Boris, Kleber, Marcus E., Lenders, Malte, Delgado, Graciela E., Engelbertz, Christiane, Huang, Jie, Pavenstädt, Hermann, Breithardt, Günter, Brand, Stefan-Martin, März, Winfried, Brand, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391429/ https://www.ncbi.nlm.nih.gov/pubmed/30809046 http://dx.doi.org/10.1038/s41598-019-39055-y

Ejemplares similares

Baseline Characteristics and Prescription Patterns of Standard Drugs in Patients with Angiographically Determined Coronary Artery Disease and Renal Failure (CAD-REF Registry)
por: Reinecke, Holger, et al.
Publicado: (2016)

Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry
por: Engelbertz, Christiane, et al.
Publicado: (2021)

Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
por: Schelleckes, Katrin, et al.
Publicado: (2017)

Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
por: Lenders, Malte, et al.
Publicado: (2018)

ZFP226 is a novel artificial transcription factor for selective activation of tumor suppressor KIBRA
por: Schelleckes, Katrin, et al.
Publicado: (2018)

α-Galactosidase a Deficiency in Fabry Disease Leads to Extensive Dysregulated Cellular Signaling Pathways in Human Podocytes
por: Jehn, Ulrich, et al.
Publicado: (2021)

Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
por: Lenders, Malte, et al.
Publicado: (2013)

Fabry disease – a multisystemic disease with gastrointestinal manifestations
por: Lenders, Malte, et al.
Publicado: (2022)

Fabry Disease: The Current Treatment Landscape
por: Lenders, Malte, et al.
Publicado: (2021)

Mechanisms of Neutralizing Anti-drug Antibody Formation and Clinical Relevance on Therapeutic Efficacy of Enzyme Replacement Therapies in Fabry Disease
por: Lenders, Malte, et al.
Publicado: (2021)

Assessment and impact of dose escalation on anti-drug antibodies in Fabry disease
por: Lenders, Malte, et al.
Publicado: (2022)

Data on gender and subgroup specific analyses of omega-3 fatty acids in the Ludwigshafen Risk and Cardiovascular Health Study
por: Kleber, Marcus E., et al.
Publicado: (2016)

Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study
por: Reinecke, Holger, et al.
Publicado: (2018)

Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 Levels
por: Schmitz, Boris, et al.
Publicado: (2017)

Effect of the rs2259816 polymorphism in the HNF1A gene on circulating levels of c-reactive protein and coronary artery disease (the ludwigshafen risk and cardiovascular health study)
por: Kleber, Marcus E, et al.
Publicado: (2010)

Telomere length and mortality in the Ludwigshafen Risk and Cardiovascular Health study
por: Pusceddu, Irene, et al.
Publicado: (2018)

In Vitro and In Vivo Amenability to Migalastat in Fabry Disease
por: Lenders, Malte, et al.
Publicado: (2020)

Characterization of pre-existing anti-PEG and anti-AGAL antibodies towards PRX-102 in patients with Fabry disease
por: Lenders, Malte, et al.
Publicado: (2023)

The association of high-normal international-normalized-ratio (INR) with mortality in patients referred for coronary angiography
por: Delgado, Graciela E., et al.
Publicado: (2019)

Pre-existing anti-drug antibodies in Fabry disease show less affinity for pegunigalsidase alfa
por: Lenders, Malte, et al.
Publicado: (2022)

Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A -10T genotype
por: Schelleckes, Michael, et al.
Publicado: (2014)

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography
por: Sommerer, Claudia, et al.
Publicado: (2019)

Gender- and subgroup-specific sensitivity analysis of alcohol consumption and mortality in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study
por: Moissl, Angela P., et al.
Publicado: (2022)

Independent Effects of Kidney Function and Cholesterol Efflux on Cardiovascular Mortality
por: Ritsch, Andreas, et al.
Publicado: (2022)

Endothelial Dysfunction in Fabry Disease Is Related to Glycocalyx Degradation
por: Pollmann, Solvey, et al.
Publicado: (2021)

Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
por: Lenders, Malte, et al.
Publicado: (2016)

Combined Use of Serum Uromodulin and eGFR to Estimate Mortality Risk
por: Yazdani, Babak, et al.
Publicado: (2021)

Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease
por: Pogoda, Christian, et al.
Publicado: (2023)

Clusters of prediabetes and type 2 diabetes stratify all-cause mortality in a cohort of participants undergoing invasive coronary diagnostics
por: Prystupa, Katsiaryna, et al.
Publicado: (2023)

Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study—Impact for mortality
por: Woitas, Rainer P., et al.
Publicado: (2017)

The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
por: Yazdani, Babak, et al.
Publicado: (2022)

Anemia of Chronic Disease in Patients With Cardiovascular Disease
por: Lanser, Lukas, et al.
Publicado: (2021)

rs41291957 controls miR‐143 and miR‐145 expression and impacts coronary artery disease risk
por: Hall, Ignacio Fernando, et al.
Publicado: (2021)

Generation and Characterization of a Polyclonal Human Reference Antibody to Measure Anti-Drug Antibody Titers in Patients with Fabry Disease
por: Lenders, Malte, et al.
Publicado: (2021)

Blood Pressure and Mortality in the 4D Study
por: Yazdani, Babak, et al.
Publicado: (2023)

Left Bundle Branch Block, an Old–New Entity
por: Breithardt, Günter, et al.
Publicado: (2012)

ATP7B knockout disturbs copper and lipid metabolism in Caco-2 cells
por: Guttmann, Sarah, et al.
Publicado: (2020)

Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential Pathophysiologies
por: Krohn, Jona B., et al.
Publicado: (2022)

MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy): cardiac resynchronization therapy towards early management of heart failure
por: Breithardt, Günter
Publicado: (2009)

Commentary: MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload-Induced Heart Failure
por: Schmitz, Boris, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e2ehbmfg9a77dqnmpcvvq25e0i